Lung transplant is a potential life-saving procedure for chronic lung diseases. Lung
transplant recipients (LTRs) are at the greatest risk for invasive fungal infections (IFIs) …

Background: Invasive fungal infection (IFI) remains a common complication after lung
transplantation, causing significant morbidity and mortality. We have attempted to quantify …

Importance The antifungal medication voriconazole is used to prevent and treat
aspergillosis, a major cause of mortality among recipients of lung transplants (hereinafter …

The first lung transplant was performed in 1963. 1 Since then, lung transplantation has
emerged as a potential lifesaving treatment modality for endstage chronic obstructive …

Background: Mucormycosis is considered the fourth most common invasive fungal disease
after candidiasis, aspergillosis and cryptococcosis. Lichtheimia species accounted for 5 …

The long-term survival after lung transplantation (LT) is favorable in Japan. However, long-
term survivors after LT are subject to late complications, including chronic lung allograft …

Long-term survival after lung transplantation is lower than that associated with other
transplanted organs. Infectious complications, most importantly invasive fungal infections …

Background Fungi of the genus S cedosporium are emerging pathogens responsible for
severe infections in lung transplant recipients. These infections are associated with poor …

Invasive fungal infections threaten lung transplant outcomes with high associated morbidity
and mortality. Pharmacologic prophylaxis may be key to prevent posttransplant invasive …

Lung transplantation is an increasingly utilized modality for treating advanced lung disease.
However, lung transplant recipients (LTRs) experience high rates of infection-related …